Drug General Information
Drug ID	D02RVN
Former ID	DIB010636
Drug Name	Selurampanel
Synonyms	BGG-492; BGG-492A; AMPA antagonist (oral, epilepsy), Novartis
Drug Type	Small molecular drug
Indication	Epilepsy [ICD10:G40]		Phase 2	[523372]
Company	Novartis pharmaceuticals
Structure		Download 2D MOL 3D MOL
Formula	C16H19N5O4S
Canonical SMILES	CS(=O)(=O)Nn1c(=O)[nH]c2c(c1=O)cc(c(c2)C(C)C)c1n(ncc1)C
CAS Number	CAS 912574-69-7
PubChem Compound ID	45381907
Target and Pathway
Target(s)	Glutamate receptor AMPA subtype	Target Info	Antagonist	[532519]
References
Ref 523372	ClinicalTrials.gov (NCT01302873) Study of BGG492 in Patients With Chronic Subjective Tinnitus. U.S. National Institutes of Health.
Ref 532519	BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy. Expert Opin Investig Drugs. 2014 Jan;23(1):107-13.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.